Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Yano

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biochemistry|November 4, 1986
Purification and characterization of a molecular weight 100,000 coat protein from coated vesicles obtained from bovine brainK Prasad, T Yora, O Yano, et al.
Microbiology and Immunology|January 1, 1992
DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growthS Yamamoto, T Yamamoto, S Shimada, et al.
Microbiology and Immunology|January 1, 1992
Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cellsT Tokunaga, O Yano, E Kuramoto, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1992
Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCGT Kataoka, S Yamamoto, T Yamamoto, et al.
Cell Structure and Function|February 1, 1991
Cloning and sequencing of viral integration site in human fibroblasts immortalized by simian virus 40O Yano, H Hirano, Y Karasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genesA Israël, A Kimura, M Kieran, et al.
Journal of the National Cancer Institute|March 1, 1985
Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumorsS Shimada, O Yano, H Inoue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Reversal of multidrug resistance by a novel quinoline derivative, MS-209W Sato, N Fukazawa, O Nakanishi, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Oligonucleotide sequences required for natural killer cell activationE Kuramoto, O Yano, Y Kimura, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cellsM Baba, O Nakanishi, W Sato, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biochemistry|November 4, 1986
Purification and characterization of a molecular weight 100,000 coat protein from coated vesicles obtained from bovine brainK Prasad, T Yora, O Yano, et al.
Microbiology and Immunology|January 1, 1992
DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growthS Yamamoto, T Yamamoto, S Shimada, et al.
Microbiology and Immunology|January 1, 1992
Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cellsT Tokunaga, O Yano, E Kuramoto, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1992
Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCGT Kataoka, S Yamamoto, T Yamamoto, et al.
Cell Structure and Function|February 1, 1991
Cloning and sequencing of viral integration site in human fibroblasts immortalized by simian virus 40O Yano, H Hirano, Y Karasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1987
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genesA Israël, A Kimura, M Kieran, et al.
Journal of the National Cancer Institute|March 1, 1985
Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumorsS Shimada, O Yano, H Inoue, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Reversal of multidrug resistance by a novel quinoline derivative, MS-209W Sato, N Fukazawa, O Nakanishi, et al.
Japanese Journal of Cancer Research : Gann|November 1, 1992
Oligonucleotide sequences required for natural killer cell activationE Kuramoto, O Yano, Y Kimura, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cellsM Baba, O Nakanishi, W Sato, et al.
Pageof 4